http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ME-P36508-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2007-04-30^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272c95afa1faddab13f25cc9cda71454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aeea6de5a5d0e735261a97ef98ea66c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6804fcb4b11eea9d67a09672559ce9b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c86c39231bb0d8d102a342a11be81a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505f6288040fbba429f88f1872140b4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf2c808c2e7e470c76006db621b88b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a7ceec260e26e91e25bd1c6cf51d000
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a6402d447e9aa7e48a68854cf98ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82e63c2d72ed7ad536b7523e9432431c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b4d080d60d1bddae04277847c6e350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a622fe94e1f04715047930a0de631d
publicationDate 2011-02-10^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ME-P36508-A
titleOfInvention TRIAZOLO PYRAZINE DERIVATIVES USEFUL AS ANTICANCEROGENIC AGENTS
abstract The invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R 1, R 2, R 3 and R 4 are as defined herein. The invention also relates to pharmaceutical compositions comprising compounds of formula I and to methods for treating hyperproliferative disorders in mammals using compounds of formula (I).
priorityDate 2006-05-11^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415831785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136241

Showing number of triples: 1 to 29 of 29.